News

USHK News
2022.09.28 08:22

渤健 (Biogen) 盘前暴涨超 55%，Eisai 和渤健宣布共同研发的新药 Lecanemab 在大型试验中显示能明显减缓阿尔茨海默症病情发展。

Source: USHK News The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.